VAM
RPTP

Visium Asset Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Visium Asset Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-11,100
Closed -$175K – 1418
2015
Q2 		$175K Buy
+11,100
New +$135K ﹤0.01% 1000

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Visium Asset Management's RPTP Position: Q3 2015 in Review

Visium Asset Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2015, closing a stake of 11,100 shares — an estimated $175K sold.

Visium Asset Management first reported a position in RPTP in Q2 2015 and held it in 1 quarter. The position peaked at $175K in Q2 2015. 106 funds tracked by Wall St. Rank hold RPTP as of Q3 2015.

  • Visium Asset Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2015 after selling out during the quarter.
  • Visium Asset Management sold 11,100 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2015, an estimated $175K.
  • Visium Asset Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2015 and held it in 1 quarter.
  • Visium Asset Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $175K in Q2 2015.
  • 106 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2015.

Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.